NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Hologic, Inc. (HOLX) Stock Analysis

Hologic, Inc. (HOLX) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

HOLX

$76.01

$0.00 (0.00%)

Last trade April 7, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HOLX with… →

HOLX Key Statistics

As of Apr 7, 2026
Trading
Open
$76.01
Previous Close
$76.01
52-Week Range
51.90–76.07
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.70
Valuation
Market Cap
$16.97B
P/E Ratio
31.54
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
15.64
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
4.11
EPS (ttm)Profit attributable to each share over the last twelve months.
2.41
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
13.18%
1-Year Return
+24.06%
Dividend and dates
Avg Volume
4.61M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HOLX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+2.04%
2025+3.33%
2024 (partial year)+1.88%

As of April 7, 2026.

HOLX Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricHOLXMedical Instruments & Supplies medianvs median
P/E31.5435.6111% below
P/S ratio4.113.1730% above
Profit margin13.18%0.85%12.3 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Hologic, Inc. (HOLX) at $16.97B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 7,070 employees.

HOLX last closed at $76.01 on April 7, 2026. The close was unchanged from the previous session. The 52-week range on file runs from $51.90 to $76.07. The latest close sits 46.45% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is $4.13B. The reported profit margin is 13.18%. That is 12.3 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 2.41.

Valuation Assessment

HOLX trades at a trailing price-to-earnings ratio of 31.54. That is 11.44% below the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 15.64. The price-to-sales ratio is 4.11. On price-to-sales that is 29.61% above the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

Over the trailing twelve months the price has returned +24.06%. Beta against the wider market is reported at 0.7. Annualized volatility over the trailing 1 year is 24.84%.

Growth & Income

The record shows no dividend for HOLX.

So far in 2026 the price is +2.04%. The record holds one complete calendar year, 2025, which returned +3.33%.

Peer Comparison

Hologic, Inc. (HOLX) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Hologic, Inc. HOLX $16.97B 31.5
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Hologic, Inc. trades at a P/E of 31.5.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of April 7, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Hologic, Inc.

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Visit website →